83. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57(8):1331-1346. 84. Zeng C, Dubreuil M, LaRochelle MR, et al. Association of Tramadol With All-Cause Mortality Among Patients With Osteoarthritis. Jama. 2019;321(10):969-982. 85. Drug Enforcement Administration. Tramadol information. Diversion Control Division, Drug & Chemical Evaluation Section. 2018. 86. Santos J, Alarcao J, Fareleira F, Vaz-Carneiro A, Costa J. Tapentadol for chronic musculoskeletal pain in adults. The Cochrane database of systematic reviews. 2015(5):CD009923. 87. Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health. Annals of internal medicine. 2017;167(5):293-301. 88. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Annals of internal medicine. 2010;152(2):85-92. 89. Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug and alcohol dependence. 2012;125(1-2):8-18. 90. Tuteja AK, Biskupiak J, Stoddard GJ, Lipman AG. Opioid- induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil. 2010;22(4):424-430. 91. Hale M, Wild J, Reddy J, Yamada T, Arjona Ferreira JC. Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials. Lancet Gastroenterol Hepatol. 2017;2(8):555-564. 92. Miller M, Sturmer T, Azrael D, Levin R, Solomon DH. Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc. 2011;59(3):430-438. 93. Dublin S, Walker RL, Jackson ML, et al. Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study. J Am Geriatr Soc. 2011;59(10):1899-1907. 94. Li L, Setoguchi S, Cabral H, Jick S. Opioid use for noncancer pain and risk of myocardial infarction amongst adults. Journal of internal medicine. 2013;273(5):511-526. 95. Deyo RA, Smith DH, Johnson ES, et al. Prescription opioids for back pain and use of medications for erectile dysfunction. Spine. 1976;38(11):909-915. 96. Review. IfCaE. Abuse Deterrent Formulations of Opioids: Effectiveness and Value Final Evidence Report. 2017. 97. Lee TH. Zero Pain Is Not the Goal. Jama. 2016;315(15):1575-1577. 98. Brummett CM, Waljee JF, Goesling J, et al. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA Surg. 2017;152(6):e170504. 99. Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use. Journal of general internal medicine. 2016;31(5):478-485. 100. Bateman BT, Franklin JM, Bykov K, et al. Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naive women. Am J Obstet Gynecol. 2016;215(3):353 e351-353 e318. 101. Johnson SP, Chung KC, Zhong L, et al. Risk of Prolonged Opioid Use Among Opioid-Naive Patients Following Common Hand Surgery Procedures. The Journal of hand surgery. 2016;41(10):947-957 e943. 102. Brat GA, Agniel D, Beam A, et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ. 2018;360:j5790. 103. Hall MJ, Schwartzman A, Zhang J, Liu X. Ambulatory Surgery Data From Hospitals and Ambulatory Surgery Centers: United States, 2010. Natl Health Stat Report. 2017(102):1-15. 104. Fishman SM. Responsible Opioid Prescribing: A Clinician’s Guide, 2nd Ed. Washington, DC: Waterford Life Sciences; 2012.
105. Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. British journal of anaesthesia. 1997;78(5):606-617. 106. American Pain Society. Management of acute pain and chronic noncancer pain. http://americanpainsociety.org/ education/enduring-materials. Accessed October 29 2018. 107. Frogner BK, Harwood K, Andrilla CHA, Schwartz M, Pines JM. Physical Therapy as the First Point of Care to Treat Low Back Pain: An Instrumental Variables Approach to Estimate Impact on Opioid Prescription, Health Care Utilization, and Costs. Health Serv Res. 2018;53(6):4629- 4646. 108. Centers for Disease Control & Prevention. Module 2: Treating Pain Without Opioids. Course number WB2859. https://www.cdc.gov/drugoverdose/training/nonopioid. Published 2018. Accessed February 10, 2019. 109. 1American Geriatrics Society Beers Criteria Update Expert P. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616-631. 110. Food and Drug Administration. Don’t double up on acetaminophen. https://www.fda.gov/consumers/ consumer-updates/dont-double-acetaminophen. Published 2018. Accessed July 12 2019. 111. Paice JA, Ferrans CE, Lashley FR, Shott S, Vizgirda V, Pitrak D. Topical capsaicin in the management of HIV-associated peripheral neuropathy. J Pain Symptom Manage. 2000;19(1):45-52. 112. Low PA, Opfer-Gehrking TL, Dyck PJ, Litchy WJ, O’Brien PC. Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain. 1995;62(2):163-168. 113. Macintyre PE, Ready LB. Acute Pain Management: A Practical Guide, 2nd Ed. London: Saunders; 2003. 114. Goodman CW, Brett AS. Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern? N Engl J Med. 2017;377(5):411-414. 115. Mathieson S, Maher CG, McLachlan AJ, et al. Trial of Pregabalin for Acute and Chronic Sciatica. N Engl J Med. 2017;376(12):1111-1120. 116. Blendon RJ, Benson JM. The Public and the Opioid-Abuse Epidemic. N Engl J Med. 2018;378(5):407-411. 117. Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569-576. 118. Wu CL, Raja SN. Treatment of acute postoperative pain. Lancet. 2011;377(9784):2215-2225. 119. Chang AK, Bijur PE, Esses D, Barnaby DP, Baer J. Effect of a Single Dose of Oral Opioid and Nonopioid Analgesics on Acute Extremity Pain in the Emergency Department: A Randomized Clinical Trial. Jama. 2017;318(17):1661- 1667. 120. Poonai N, Datoo N, Ali S, et al. Oral morphine versus ibuprofen administered at home for postoperative orthopedic pain in children: a randomized controlled trial. CMAJ. 2017;189(40):E1252-E1258. 121. Hunold KM, Esserman DA, Isaacs CG, et al. Side effects from oral opioids in older adults during the first week of treatment for acute musculoskeletal pain. Acad Emerg Med. 2013;20(9):872-879. 122. Solomon DH, Rassen JA, Glynn RJ, Lee J, Levin R, Schneeweiss S. The comparative safety of analgesics in older adults with arthritis. Archives of internal medicine. 2010;170(22):1968-1976. 123. Gil JA, Gunaseelan V, DeFroda SF, Brummett CM, Bedi A, Waljee JF. Risk of Prolonged Opioid Use Among Opioid- Naive Patients After Common Shoulder Arthroscopy Procedures. Am J Sports Med. 2019;47(5):1043-1050. 124. Miller M, Barber CW, Leatherman S, et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA internal medicine. 2015;175(4):608-615.
125. Kim N, Matzon JL, Abboudi J, et al. A Prospective Evaluation of Opioid Utilization After Upper-Extremity Surgical Procedures: Identifying Consumption Patterns and Determining Prescribing Guidelines. J Bone Joint Surg Am. 2016;98(20):e89. 126. Michigan Opioid Prescribing Engagement Network. Opioid prescribing recommendations for surgery. https:// opioidprescribing.info/. Published 2019. Accessed May 1 2019. 127. Kroenke K, Bair MJ, Damush TM, et al. Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. Jama. 2009;301(20):2099-2110. 128. Payne R, Anderson E, Arnold R, et al. A rose by any other name: pain contracts/agreements. The American journal of bioethics : AJOB. 2010;10(11):5-12. 129. Roskos SE, Keenum AJ, Newman LM, Wallace LS. Literacy demands and formatting characteristics of opioid contracts in chronic nonmalignant pain management. J Pain. 2007;8(10):753-758. 130. Fishman SM, Mahajan G, Wilsey B. Author response to: The trilateral opioid contract: bridging the pain clinic and the primary care physician through the opioid contract. J Pain Symptom Manage. 2003;25(5):403. 131. Chu J, Farmer B, Ginsburg B, et al. New York City emergency department discharge opioid prescribing guidelines. https://www1.nyc.gov/site/doh/providers/health- topics/opioid-prescribing-resources-for-emergency- departments.page. Published 2013. Accessed November 9 2018. 132. Cheng D, Majlesi N. Clinical practice statement: emergency department opioid prescribing guidelines for the treatment of noncancer related pain. Milwaukee, WI: American Academy of Emergency Medicine; 2013. 133. Thorson D, Biewen P, Bonte B, et al. Acute pain assessment and opioid prescribing protocol. Institute for Clinical Systems Improvement. https://www.icsi.org. Published 2014. Accessed November 9 2018. 134. Paone D, Dowell D, Heller D. Preventing misuse of prescription opioid drugs. City Health Information. 2011;30:23-30. 135. Cantrill SV, Brown MD, Carlisle RJ, et al. Clinical policy: critical issues in the prescribing of opioids for adult patients in the emergency department. Annals of emergency medicine. 2012;60(4):499-525. 136. Washington State Agency Medical Directors Group. Interagency Guideline on Opioid Dosing for Chronic Non- cancer Pain. 2010. 137. Webster LR, Dove B. Avoiding opioid abuse while managing pain. North Branch, MN: Sunrise River Press; 2007. 138. Knotkova H, Fine PG, Portenoy RK. Opioid rotation: the science and the limitations of the equianalgesic dose table. J Pain Symptom Manage. 2009;38(3):426-439. 139. Rudd RA, Seth P, David F, Scholl L. Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010- 2015. MMWR Morbidity and mortality weekly report. 2016;65(5051):1445-1452. 140. VA/DoD. The management of opioid therapy for chronic pain working group. VA/DoD clinical practice guidelines for the management of opiod therapy for chronic pain. 2003(contract number: V101 (93)). 141. Food and Drug Administration. FDA approves first generic naloxone nasal spray to treat opioid overdose. FDA News Release. April 19 2019. 142. Frank JW, Lovejoy TI, Becker WC, et al. Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review. Annals of internal medicine. 2017;167(3):181-191. 143. Berna C, Kulich RJ, Rathmell JP. Tapering Long-term Opioid Therapy in Chronic Noncancer Pain: Evidence and Recommendations for Everyday Practice. Mayo Clin Proc. 2015;90(6):828-842.
67
Powered by FlippingBook